Cannabis Watch: Marijuana stocks to watch: Meet the drugmaker making cannabis-based medicines for autism, cancer and more

The following article is part of a package of stories that MarketWatch is publishing to mark the start of full legalization of cannabis for adult use in Canada on Wednesday.

The cannabis sector has been making waves lately, as Canada legalizes weed and companies see potential for CBD-infused drinks.

But cannabis is also expected to have many medical applications. One of the major players in the space is the Cambridge, U.K.-based GW Pharmaceuticals PLC GWPH, -2.90% which has been working to develop and sell cannabinoid medications for the last 20 years.

Epidiolex, the company’s lead therapy, became the first cannabis-derived drug in the U.S.

>>> Original Source <<<